Calendar

Week of Mar 2, 2026

Mar 5, 2026grant163d agoUNIVERSITY OF PENNSYLVANIA — Training Leaders to Improve Outcomes in Older Adults Using Advanced MethodsUniversity of Pennsylvania

AG grant. $214,223. PI: Robert Edward Burke

full page →nih reporter ↗

Mar 5, 2026grant163d agoUNIVERSITY OF COLORADO — The Menses Study: Menstrual blood as a novel target-tissue biomatrix for chem...

OD grant. $434,110. PI: Jenni Shearston

full page →nih reporter ↗

Mar 5, 2026grant163d agoNEW YORK UNIVERSITY — Neural circuit mechanisms of dynamic learning ratesNew York University

MH grant. $710,563. PI: Christine M Constantinople

full page →nih reporter ↗

Mar 5, 2026grant163d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Mapping the Mechanome: A Systems-level Understanding of Mechanical Mediators ...University of California Los Angeles

GM grant. $433,125. PI: Amy C Rowat

full page →nih reporter ↗

Mar 5, 2026grant163d agoBOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — Advancing targeted delivery of intracellular protein therapeutics

GM grant. $449,625. PI: Samagya Banskota

full page →nih reporter ↗

Mar 5, 2026grant163d agoUNIVERSITY OF IOWA — Role of Notch Pathway in the Pathogenesis of Chronic PancreatitisUniversity of Iowa

DK grant. $655,482. PI: VIKAS DUDEJA

full page →nih reporter ↗

Mar 5, 2026grant163d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Controlling epilepsy symptoms with precisely timed inhibition and circuit edi...

NS grant. $75,880. PI: Christopher David Adam

full page →nih reporter ↗

Mar 5, 2026grant163d agoUT SOUTHWESTERN MEDICAL CENTER — The roles of Rett Syndrome protein MECP2 at gene regulatory elements

MH grant. $641,828. PI: Hume Akahori Stroud

full page →nih reporter ↗

Mar 5, 2026grant163d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Loneliness and inflammatory markers as biopsychosocial pathways to AD/ADRD: A...

AG grant. $121,239. PI: Mara Getz Sheftel

full page →nih reporter ↗

Mar 5, 2026grant163d agoCINCINNATI CHILDRENS HOSP MED CTR — Impact of Circadian Misalignment for Adolescents with ADHD: Observational and...

MH grant. $820,196. PI: Stephen P Becker

full page →nih reporter ↗

Mar 5, 2026grant163d agoUNIVERSITY OF IOWA — Investigating single cell transcriptomics and epigenetic regulation to enable...University of Iowa

MH grant. $779,797. PI: Rainbo Hultman

full page →nih reporter ↗

Mar 5, 2026grant163d agoHENRY M. JACKSON FDN FOR THE ADV MIL/MED — Neural Plasticity and Myelin Dynamics after Amputation

NS grant. $555,265. PI: Emily Rose Petrus

full page →nih reporter ↗

Mar 5, 2026grant163d agoPUBLIC HEALTH FOUNDATION ENTERPRISES — PrEP Blueprint: Evaluating implementation of a PrEP Choice Blueprint on PrEP ...

MH grant. $659,242. PI: Hyman Scott

full page →nih reporter ↗

Mar 5, 2026grant163d agoSTANFORD UNIVERSITY — The role of expected informativity on linguistic and memory encodingStanford University

DC grant. $124,686. PI: Eleonora Judith Beier

full page →nih reporter ↗

Mar 5, 2026grant163d agoEMORY UNIVERSITY — A Foot in Each World: Bridging the Divide Between Clinical Research and the M...Emory University

MH grant. $156,500. PI: Santiago Jose Arconada Alvarez

full page →nih reporter ↗

Mar 5, 2026grant163d agoBRIGHAM AND WOMEN'S HOSPITAL — Cellular Therapy for Sepsis and Lung InjuryBrigham and Women's Hospital

GM grant. $445,983. PI: Mark A PERRELLA

full page →nih reporter ↗

Mar 5, 2026grant163d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Mechanisms that regulate cellular responses to phosphate

GM grant. $429,000. PI: Lauren Elizabeth Surface

full page →nih reporter ↗

Mar 5, 2026grant163d agoPENNSYLVANIA STATE UNIVERSITY, THE — Investigating brain-body allostasis via longitudinal in vivo imaging

GM grant. $407,603. PI: Grayson Oren Sipe

full page →nih reporter ↗

Mar 5, 2026grant163d agoUNIVERSITY OF MARYLAND BALTIMORE — SGLT2 - Novel Molecular Mechanism of AQP4 Regulation

NS grant. $602,065. PI: J. Marc Simard

full page →nih reporter ↗

Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval162d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval162d agoQUDEXY XR (TOPIRAMATE) — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoPYLARIFY TRUVU (PIFLUFOLASTAT F-18) — FDA approval

Sponsor: APHELION. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval162d agoQSYMIA (PHENTERMINE HYDROCHLORIDE) — FDA approval(phentermine hydrochloride + topiramate) ER

Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →(phentermine hydrochloride + topiramate) ER →fda approvals ↗

Mar 6, 2026approval162d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoXELJANZ XR (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Mar 6, 2026approval162d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval162d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval162d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoSIPONIMOD — FDA approvalSIPONIMOD

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →SIPONIMOD →fda approvals ↗

Mar 6, 2026approval162d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Mar 6, 2026approval162d agoSOTYKTU (DEUCRAVACITINIB) — FDA approvalBristol-Myers Squibb Co

Sponsor: BRISTOL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoTROKENDI XR (TOPIRAMATE) — FDA approvalSUPERNUS PHARMACEUTICALS, INC.

Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval162d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗

Mar 6, 2026approval162d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: PRINSTON INC. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Mar 6, 2026approval162d agoEVEROLIMUS — FDA approvalEVEROLIMUS

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →EVEROLIMUS →fda approvals ↗

Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

full page →Restasis →fda approvals ↗

Mar 6, 2026approval162d agoEPRONTIA (TOPIRAMATE) — FDA approvaltopiramate ER

Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

full page →topiramate ER →fda approvals ↗

Mar 6, 2026approval162d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval162d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: SOLUTION. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Mar 6, 2026device 510k162d agoTreace Medical Concepts, Inc. — Treace Medical Concepts (TMC) Screw Fixation System (510k cleared)TREACE MEDICAL CONCEPTS, INC.

Product code: HWC. Advisory committee: Orthopedic. Type: Special

full page →fda device 510k ↗

Mar 6, 2026device 510k162d agoOlympus Medical Systems Corp. — Single Use Electrosurgical Hemostatic Forceps FD-410LR, FD-411UR, FD-412LR (510k cleared)

Product code: KGE. Advisory committee: Gastroenterology, Urology. Type: Traditional

full page →fda device 510k ↗

Mar 6, 2026device 510k162d agoTheramicro — TeKBrace Knotless Anchor (510k cleared)

Product code: MBI. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗

Mar 6, 2026device 510k162d agoZhejiang Chuangxiang Medical Technology Co., Ltd. — Single use stone retrieval balloons (510k cleared)Zhejiang Xinkanghe Biomedical Technology Co Ltd

Product code: FGE. Advisory committee: Gastroenterology, Urology. Type: Traditional

full page →fda device 510k ↗

Mar 6, 2026device 510k162d agoGuangzhou Potent Medical Equipment Joint-Stock Co., Ltd. — Holmium Laser Therapeutic Apparatus (HZ-A); Holmium Laser Therapeutic Apparatus (HZ-B); Holmium Laser Therapeutic Apparatus (HZ-E) (510k cleared)

Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

full page →fda device 510k ↗

Mar 6, 2026device 510k162d agoBunkerHill Health — Bunkerhill Contrast AVC (510k cleared)

Product code: JAK. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗

Mar 6, 2026device 510k162d agoCalyxo, Inc. — CVAC Image Processor (510k cleared)

Product code: FGB. Advisory committee: Gastroenterology, Urology. Type: Traditional

full page →fda device 510k ↗

Mar 6, 2026device 510k162d agoAdeor Medical AG — Velocity Alpha MR High Speed Surgical Drill System (510k cleared)

Product code: HBB. Advisory committee: Neurology. Type: Traditional

full page →fda device 510k ↗

← prev

page 15 of 160

Week of Mar 2, 2026